Your browser doesn't support javascript.
loading
Rudimentary TCR signaling triggers default IL-10 secretion by human Th1 cells.
Burrows, G G; Chou, Y K; Wang, C; Chang, J W; Finn, T P; Culbertson, N E; Kim, J; Bourdette, D N; Lewinsohn, D A; Lewinsohn, D M; Ikeda, M; Yoshioka, T; Allen, C N; Offner, H; Vandenbark, A A.
Afiliación
  • Burrows GG; Department of Neurology, Oregon Health and Science University, Portland, OR 97201, USA. ggb@ohsu.edu
J Immunol ; 167(8): 4386-95, 2001 Oct 15.
Article en En | MEDLINE | ID: mdl-11591763
ABSTRACT
Understanding the process of inducing T cell activation has been hampered by the complex interactions between APC and inflammatory Th1 cells. To dissociate Ag-specific signaling through the TCR from costimulatory signaling, rTCR ligands (RTL) containing the alpha1 and beta1 domains of HLA-DR2b (DRA*0101DRB1*1501) covalently linked with either the myelin basic protein peptide 85-99 (RTL303) or CABL-b3a2 (RTL311) peptides were constructed to provide a minimal ligand for peptide-specific TCRs. When incubated with peptide-specific Th1 cell clones in the absence of APC or costimulatory molecules, only the cognate RTL induced partial activation through the TCR. This partial activation included rapid TCR zeta-chain phosphorylation, calcium mobilization, and reduced extracellular signal-related kinase activity, as well as IL-10 production, but not proliferation or other obvious phenotypic changes. On restimulation with APC/peptide, the RTL-pretreated Th1 clones had reduced proliferation and secreted less IFN-gamma; IL-10 production persisted. These findings reveal for the first time the rudimentary signaling pattern delivered by initial engagement of the external TCR interface, which is further supplemented by coactivation molecules. Activation with RTLs provides a novel strategy for generating autoantigen-specific bystander suppression useful for treatment of complex autoimmune diseases.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Antígeno HLA-DR2 / Interleucina-10 / Células TH1 Límite: Humans Idioma: En Revista: J Immunol Año: 2001 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Antígeno HLA-DR2 / Interleucina-10 / Células TH1 Límite: Humans Idioma: En Revista: J Immunol Año: 2001 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA